Medical Devices UAE

UAE Infectious Disease Molecular Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

UAE Infectious Disease Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Disease, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $83.9 Mn Placeholder estimate
Estimate 2025 $88.7 Mn 0.5% of the global market
Projected 2034 $146.1 Mn 64.7% Adds $57.4 Mn over 9 forecast years
CAGR 2025–2034 5.7% Faster than 2% of 173 Medical Devices markets here
Key players 5
  • UAE is 0.5% of the global market.
  • In Middle East, the largest is Saudi Arabia at $289.0 Mn.
  • Fastest growing: Saudi Arabia at 6.9% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$57.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Infectious Disease Molecular Diagnostics Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $83.9 Mn — —
2025 (base) $88.7 Mn +$4.8 Mn —
2026 (forecast) $93.8 Mn +$5.1 Mn +5.7%
2027 (forecast) $99.1 Mn +$5.3 Mn +11.7%
2028 (forecast) $104.8 Mn +$5.6 Mn +18.1%
2029 (forecast) $110.7 Mn +$6.0 Mn +24.8%
2030 (forecast) $117.0 Mn +$6.3 Mn +31.9%
2031 (forecast) $123.7 Mn +$6.7 Mn +39.5%
2032 (forecast) $130.8 Mn +$7.1 Mn +47.4%
2033 (forecast) $138.2 Mn +$7.5 Mn +55.8%
2034 (forecast) $146.1 Mn +$7.9 Mn +64.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $17.64 Bn
  2. North America $8.99 Bn
  3. US $7.64 Bn
  4. Europe $3.25 Bn
  5. APAC $3.37 Bn
  6. China $1.64 Bn
  7. Canada $1.25 Bn
  8. Japan $1.23 Bn
  9. Latin America $740.2 Mn
  10. Germany $707.8 Mn
  11. Middle East $724.6 Mn
  12. France $516.7 Mn
  13. UK $497.6 Mn
  14. Brazil $507.1 Mn
  15. Italy $475.2 Mn
  16. Ecuador $399.6 Mn
  17. Spain $292.5 Mn
  18. India $303.9 Mn
  19. Saudi Arabia $289.0 Mn
  20. Africa $259.2 Mn
  21. Mexico $243.4 Mn
  22. Australia $234.1 Mn
  23. Russia $189.8 Mn
  24. New Zealand $151.2 Mn
  25. South Africa $123.0 Mn
  26. UAE (this report) $88.7 Mn
  27. Egypt $48.2 Mn
  28. Philippines $43.0 Mn
  29. Malaysia $28.4 Mn
  30. Hong Kong $25.9 Mn
  31. Thailand $23.7 Mn
  32. Singapore $18.5 Mn
  33. Kenya $11.9 Mn

Report snapshot

UAE Infectious Disease Molecular Diagnostics Market Analysis at a glance
Market size, 2025$88.7 Mn placeholder estimate
Forecast, 2034$146.1 Mn placeholder estimate
Growth (CAGR), 2025–20345.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease, technology and end user (see all)
Key playersRoche Diagnostics, Abbott Laboratories, Hologic, Inc., Cepheid, bioMérieux SA (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Infectious Disease Molecular Diagnostics Market Analysis Executive Summary

Infectious disease molecular diagnostics detect the DNA or RNA of germs to diagnose infections accurately and quickly.

Key segments of the infectious Disease Molecular Diagnostics market include disease (Respiratory, HIV and Hepatitis and STIs) and technology (PCR, Isothermal and Sequencing).

Bar chart: UAE Infectious Disease Molecular Diagnostics market size, 2024–2034, placeholder estimates. $83.9 Mn in 2024, $88.7 Mn in 2025 and $146.1 Mn in 2034, 5.7% CAGR.
UAE Infectious Disease Molecular Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Infectious Disease Molecular Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the infectious Disease Molecular Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the infectious Disease Molecular Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the infectious Disease Molecular Diagnostics market.

Competitive Landscape for Infectious Disease Molecular Diagnostics Market in UAE

The infectious Disease Molecular Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Infectious Disease Molecular Diagnostics Market in UAE

Infectious Disease Molecular Diagnostics in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how infectious Disease Molecular Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Infectious Disease Molecular Diagnostics right now, from free public sources.

Latest research 35 papers since 2021 (worldwide)

  1. Oxidized phospholipids: evolution, signaling, cell death, and human diseases. Science bulletin, 2026
  2. Molecular Public Health for Infectious Disease Prevention and Control. Microorganisms, 2026
  3. Evaluation of the Biosynex AMPLIQUICK(®) Fecal Parasitology assays in a Belgian travel clinic. Frontiers in cellular and infection microbiology, 2026
  4. "Metal-based compounds in antiviral and Antiparasitic research: Mechanistic insights from HIV NCp7 and leishmaniasis case studies". Journal of inorganic biochemistry, 2026
  5. Factors Influencing Choice of Laboratory-Developed Tests and US Food and Drug Administration (FDA)-Approved or FDA-Cleared In Vitro Diagnostics for Molecular Analytes. Archives of pathology & laboratory medicine, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Infectious Disease Molecular Diagnostics in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 8th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Infectious Disease Molecular Diagnostics market in the UAE?
Placeholder estimate: about $88.7 Mn in 2025, rising to about $146.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Infectious Disease Molecular Diagnostics market in the UAE growing?
Placeholder estimate: about 5.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Infectious Disease Molecular Diagnostics market report cover?
The report splits the market by disease (Respiratory, HIV and Hepatitis, STIs, Tuberculosis and more), technology (PCR, Isothermal, Sequencing) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Infectious Disease Molecular Diagnostics market?
Key players include Roche Diagnostics, Abbott Laboratories, Hologic, Inc., Cepheid and bioMérieux SA.
What is driving the Infectious Disease Molecular Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the infectious Disease Molecular Diagnostics market.
Who regulates Infectious Disease Molecular Diagnostics in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on Infectious Disease Molecular Diagnostics?
PubMed lists 35 papers on Infectious Disease Molecular Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Infectious Disease Molecular Diagnostics in UAE? Our analysts can size it for your plan. Talk to us See the public data Medicine sales: anti-infectives for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in UAE

See all
Same topic, other categories

Related on diagnostics and lab testing and infectious diseases

See the topic